Skip to main content
High RiskFDAfda-F-1387-2022UNDECLARED ALLERGEN

PurAqua Belle Vie SPARKLING WATER wellness RELAX 100mg ASHWAGANDHA PER 12 FL OZ STRAWBERRY CUCUMBER FLAVORED SPARKLING WATER WITH OTHER N...

Category
Units Affected
45,200
Recall Date
June 10, 2022
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1387-2022.

Firm indicated that the product contains undeclared caffeine.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1387-2022.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Independent Beverage Company Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1387-2022.

Independent Beverage Company LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Independent Beverage Company Llc Recall FAQ

Independent Beverage Company Llc is the subject of a beverages safety report: PurAqua Belle Vie SPARKLING WATER wellness RELAX 100mg ASHWAGANDHA PER 12 FL OZ STRAWBERRY CUCUMBER FLAVORED SPARKLING WATER WITH OTHER N.... The notice was published on June 10, 2022 by the U.S. Food and Drug Administration (FDA). Approximately 45,200 units are potentially affected.